About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

OncoTherapy Science, Inc.(4564) Financial Results

4564
TSE Growth
OncoTherapy Science, Inc.
24
JPY
0
(0.00%)
Dec 23, 3:07 pm JST
0.15
USD
Dec 23, 1:00 am EST
Result
ー
PTS
outside of trading hours
24.8
Dec 23, 3:08 pm JST
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2021 332 -1,637 -1,639 -1,561 -8.9 0 May 7, 2021 J-GAAP
Mar, 2022 1,153 -2,052 -2,071 -2,571 -13.7 0 May 6, 2022 J-GAAP
Mar, 2023 1,134 -1,106 -1,133 -1,118 -5.8 0 May 12, 2023 J-GAAP
Mar, 2024 610 -1,120 -1,136 -1,288 -6.1 0 May 10, 2024 J-GAAP
Mar, 2025 Guidance ー ー ー ー － 0 May 10, 2024 J-GAAP
YoY － － － － －
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 6,223 1,184 1,255 726 7.0
Fiscal Year Mar, 2012 Mar, 2012 Mar, 2012 Mar, 2012 Mar, 2012
Second Half
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2021 913 -1,104 -1,119 -1,342 -7.2 0 May 6, 2022 J-GAAP
Oct - Mar, 2022 620 -488 -490 -505 -2.6 0 May 12, 2023 J-GAAP
Oct - Mar, 2023 254 -426 -428 -578 -2.7 0 May 10, 2024 J-GAAP
Oct - Mar, 2024 Guidance ー ー ー ー － 0 May 10, 2024 J-GAAP
YoY － － － － －
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Mar, 2022 -2,052 -2,540 -2,073 -467 1,478 1,836 68.38 J-GAAP
Mar, 2023 -1,106 -814 -794 -20 95 1,117 73.92 J-GAAP
Mar, 2024 -1,120 -1,260 -1,227 -33 671 527 60.78 J-GAAP
Actual Performance and Financial Trends
Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 514 -618 -643 -613 -3.2 ー Nov 4, 2022 J-GAAP
Apr - Sep, 2023 356 -694 -708 -710 -3.4 ー Nov 10, 2023 J-GAAP
Apr - Sep, 2024 225 -531 -545 -545 -2.2 ー Nov 8, 2024 J-GAAP
YoY -36.8% +23.5% +23.0% +23.2% +36.3%
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2022 185 -286 -285 -300 -1.6 -154.6 Feb 10, 2023 J-GAAP
Jan - Mar, 2023 435 -202 -205 -205 -1.1 -46.4 May 12, 2023 J-GAAP
Apr - Jun, 2023 148 -386 -397 -400 -2.0 -260.8 Aug 10, 2023 J-GAAP
Jul - Sep, 2023 208 -308 -311 -310 -1.5 -148.1 Nov 10, 2023 J-GAAP
Oct - Dec, 2023 110 -278 -278 -277 -1.3 -252.7 Feb 9, 2024 J-GAAP
Jan - Mar, 2024 144 -148 -150 -301 -1.4 -102.8 May 10, 2024 J-GAAP
Apr - Jun, 2024 100 -290 -302 -302 -1.3 -290.0 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 125 -241 -243 -243 -1.0 -192.8 Nov 8, 2024 J-GAAP
YoY -39.9% +21.8% +21.9% +21.6% +34.9%
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 4,766 3,331 3,387 2,900 27.8
Fiscal Year Mar, 2012 Mar, 2012 Mar, 2012 Mar, 2012 Mar, 2012
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Mar, 2022 9.84 70.6 2,685 1,896 -23,686 ー May 6, 2022 J-GAAP
Mar, 2023 4.04 51.4 1,511 777 -24,804 ー May 12, 2023 J-GAAP
Mar, 2024 1.28 32.2 867 279 -26,092 ー May 10, 2024 J-GAAP
Apr - Sep, 2024 ー 59.9 1,548 927 -26,638 ー Nov 8, 2024 J-GAAP